Investigational Drug Details

Drug ID: D178
Drug Name: Hydroxytyrosol
Synonyms: HXT
Type: Chemical drug
DrugBank ID: DB12771
DrugBank Description: Hydroxytyrosol has been used in trials studying the prevention of Breast Cancer.
PubChem ID: 82755
CasNo: 10597-60-1
Repositioning for NAFLD: No
SMILES: C(CO)c1cc(O)c(cc1)O
Structure:
InChiKey: JUUBCHWRXWPFFH-UHFFFAOYSA-N
Molecular Weight: 154.165
DrugBank Targets: --
DrugBank MoA: --
DrugBank Pharmacology: --
DrugBank Indication: --
Targets: --
Therapeutic Category: Antioxidant
Clinical Trial Progress: Phase 3 completed (NCT02842567: The treatment with HXT and VitE reduced the NAFLD-related systemic inflammation in children, mainly by an increase of IL-10 circulating levels that occurred in response to DNA damage recovery, ultimately improving steatosis and hypertriglyceridemia.)
Latest Progress: Under clinical trials